1. Home
  2. CMP vs SLDB Comparison

CMP vs SLDB Comparison

Compare CMP & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

HOLD

Current Price

$25.63

Market Cap

1.2B

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$9.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMP
SLDB
Founded
1993
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2003
2017

Fundamental Metrics

Financial Performance
Metric
CMP
SLDB
Price
$25.63
$9.54
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$21.50
$16.36
AVG Volume (30 Days)
374.9K
764.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.97
EPS
0.59
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.29
N/A
P/E Ratio
$43.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.40
$3.79
52 Week High
$34.50
$11.45

Technical Indicators

Market Signals
Indicator
CMP
SLDB
Relative Strength Index (RSI) 47.79 53.32
Support Level $24.49 $5.21
Resistance Level $25.80 $11.45
Average True Range (ATR) 0.89 0.44
MACD 0.25 0.01
Stochastic Oscillator 72.32 54.19

Price Performance

Historical Comparison
CMP
SLDB

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: